Medicare Part D Drug Coverage List

According to the Centers for Medicare & Medicaid Services (CMS) 2026 Part D formulary data, this list covers 6,046 drugs across Medicare Part D plans, sorted by how broadly each is covered. Under the Inflation Reduction Act, Part D out-of-pocket costs are capped at $2,000 a year in 2026; see our methodology for how coverage breadth is calculated.

Coverage varies by plan and geography. Verify drug coverage with your specific plan before making decisions.

Overview Browse Drugs Part D Plans Rankings

Drug Name	Plans Covering	Coverage %	Avg Tier	PA %	2023 Benes
{28 (ethinyl estradiol 0.005 MG / norethindrone acetate 1 MG Oral Tablet) } Pack ethinyl estradiol	3,228	63.7%	T3	3.8%	-
24 HR paroxetine hydrochloride 37.5 MG Extended Release Oral Tablet paroxetine hydrochloride	3,216	63.5%	T3	26.6%	-
lidocaine hydrochloride 40 MG/ML Mucous Membrane Topical Solution lidocaine hydrochloride	3,215	63.4%	T2	47.8%	25,210
alanine 10.4 MG/ML / arginine 5.75 MG/ML / glucose 150 MG/ML / glycine 5.15 MG/ML / histidine 2.4 MG/ML / isoleucine 3 MG/ML / leucine 3.65 MG/ML / lysine 2.9 MG/ML / methionine 2 MG/ML / phenylalanine 2.8 MG/ML / proline 3.4 MG/ML / serine 2.5 MG/ML / threonine 2.1 MG/ML / tryptophan 0.9 MG/ML / tyrosine 0.2 MG/ML / valine 290 MG/ML Injectable Solution [Clinimix 5/15] alanine	3,198	63.1%	T3	97.8%	-
alanine 8.8 MG/ML / arginine 4.89 MG/ML / glucose 50 MG/ML / glycine 4.38 MG/ML / histidine 2.04 MG/ML / isoleucine 2.55 MG/ML / leucine 3.11 MG/ML / lysine 2.47 MG/ML / methionine 1.7 MG/ML / phenylalanine 2.38 MG/ML / proline 2.89 MG/ML / serine 2.13 MG/ML / threonine 1.79 MG/ML / tryptophan 0.77 MG/ML / tyrosine 0.17 MG/ML / valine 2.47 MG/ML Injectable Solution [Clinimix 4.25/5] alanine	3,198	63.1%	T3	97.8%	-
silodosin 8 MG Oral Capsule silodosin	3,197	63.1%	T3	0%	65,592
alanine 8.8 MG/ML / arginine 4.89 MG/ML / glucose 100 MG/ML / glycine 4.38 MG/ML / histidine 2.04 MG/ML / isoleucine 2.55 MG/ML / leucine 3.11 MG/ML / lysine 2.47 MG/ML / methionine 1.7 MG/ML / phenylalanine 2.38 MG/ML / proline 2.89 MG/ML / serine 2.13 MG/ML / threonine 1.79 MG/ML / tryptophan 0.77 MG/ML / tyrosine 0.17 MG/ML / valine 2.47 MG/ML Injectable Solution [Clinimix 4.25/10] alanine	3,197	63.1%	T3	97.8%	-
Pediatric 1.5 ML leuprolide acetate 7.5 MG/ML Prefilled Syringe [Lupron] Pediatric	3,194	63%	T4	94.3%	-
alanine 10.4 MG/ML / arginine 5.75 MG/ML / glucose 200 MG/ML / glycine 5.15 MG/ML / histidine 2.4 MG/ML / isoleucine 3 MG/ML / leucine 3.65 MG/ML / lysine 2.9 MG/ML / methionine 2 MG/ML / phenylalanine 2.8 MG/ML / proline 3.4 MG/ML / serine 2.5 MG/ML / threonine 2.1 MG/ML / tryptophan 0.9 MG/ML / tyrosine 0.2 MG/ML / valine 2.9 MG/ML Injectable Solution [Clinimix 5/20] alanine	3,189	62.9%	T3	97.8%	-
90 DAY estradiol 0.000313 MG/HR Vaginal System [Estring]	3,180	62.8%	T4	0%	33,506
cimetidine 300 MG Oral Tablet cimetidine	3,173	62.6%	T2	0%	29,869
cimetidine 400 MG Oral Tablet cimetidine	3,173	62.6%	T2	0%	29,869
cimetidine 800 MG Oral Tablet cimetidine	3,173	62.6%	T2	0%	29,869
silodosin 4 MG Oral Capsule silodosin	3,172	62.6%	T3	0%	65,592
budesonide 0.5 MG/ML Inhalation Suspension budesonide	3,169	62.5%	T3	99.6%	61,841
24 HR lamotrigine 250 MG Extended Release Oral Tablet lamotrigine	3,168	62.5%	T3	0%	-
60 ACTUAT olodaterol 0.0025 MG/ACTUAT / tiotropium 0.0025 MG/ACTUAT Inhalation Spray [Stiolto]	3,157	62.3%	T3	0%	-
brimonidine tartrate 1.5 MG/ML Ophthalmic Solution brimonidine tartrate	3,143	62%	T2	0%	573,214
theophylline 5.33 MG/ML Oral Solution theophylline	3,137	61.9%	T3	0%	39,063
selexipag 1.6 MG Oral Tablet [Uptravi] selexipag	3,135	61.9%	T4	99%	3,727
selexipag 0.2 MG Oral Tablet [Uptravi] selexipag	3,132	61.8%	T4	99%	3,727
selexipag 0.4 MG Oral Tablet [Uptravi] selexipag	3,132	61.8%	T4	99%	3,727
selexipag 0.6 MG Oral Tablet [Uptravi] selexipag	3,132	61.8%	T4	99%	3,727
selexipag 0.8 MG Oral Tablet [Uptravi] selexipag	3,132	61.8%	T4	99%	3,727
selexipag 1 MG Oral Tablet [Uptravi] selexipag	3,132	61.8%	T4	99%	3,727
selexipag 1.2 MG Oral Tablet [Uptravi] selexipag	3,132	61.8%	T4	99%	3,727
selexipag 1.4 MG Oral Tablet [Uptravi] selexipag	3,132	61.8%	T4	99%	3,727
{140 (selexipag 0.2 MG Oral Tablet [Uptravi]) / 60 (selexipag 0.8 MG Oral Tablet [Uptravi]) } Pack [Uptravi Titration Pack] selexipag	3,131	61.8%	T4	99%	3,727
cimetidine 200 MG Oral Tablet cimetidine	3,127	61.7%	T2	0%	29,869
arformoterol 0.0075 MG/ML Inhalation Solution arformoterol	3,125	61.7%	T3	100%	3,531
100 ML potassium chloride 0.4 MEQ/ML Injection potassium chloride	3,108	61.3%	T3	1.4%	-
magnesium sulfate 225 MG / potassium chloride 188 MG / sodium sulfate 1479 MG Oral Tablet [Sutab] magnesium sulfate	3,107	61.3%	T3	0%	929
topiramate 25 MG/ML Oral Solution [Eprontia] topiramate	3,105	61.3%	T4	40.8%	644,196
tofacitinib 5 MG Oral Tablet [Xeljanz] tofacitinib	3,100	61.2%	T4	98.5%	12,497
tofacitinib 10 MG Oral Tablet [Xeljanz] tofacitinib	3,100	61.2%	T4	98.5%	12,497
24 HR tofacitinib 11 MG Extended Release Oral Tablet [Xeljanz] tofacitinib	3,100	61.2%	T4	98.5%	6,936
24 HR tofacitinib 22 MG Extended Release Oral Tablet [Xeljanz] tofacitinib	3,100	61.2%	T4	98.5%	6,936
tofacitinib 1 MG/ML Oral Solution [Xeljanz] tofacitinib	3,096	61.1%	T4	98.5%	12,497
soybean oil 300 MG/ML Injectable Suspension [Intralipid] soybean oil	3,084	60.9%	T3	100%	51
nicardipine hydrochloride 20 MG Oral Capsule nicardipine hydrochloride	3,076	60.7%	T3	0%	1,049
Pulmonary Hypertension tadalafil 20 MG Oral Tablet [Alyq] Pulmonary Hypertension tadalafil	3,069	60.6%	T3	100%	419
24 HR diltiazem hydrochloride 240 MG Extended Release Oral Tablet diltiazem hydrochloride	3,068	60.5%	T2	0%	-
24 HR diltiazem hydrochloride 300 MG Extended Release Oral Tablet diltiazem hydrochloride	3,068	60.5%	T2	0%	-
24 HR diltiazem hydrochloride 360 MG Extended Release Oral Tablet diltiazem hydrochloride	3,068	60.5%	T2	0%	-
hydroxyzine hydrochloride 2 MG/ML Oral Solution hydroxyzine hydrochloride	3,064	60.5%	T3	54.6%	1,319,270
bisoprolol fumarate 2.5 MG Oral Tablet bisoprolol fumarate	3,064	60.5%	T2	0%	262,683
nicardipine hydrochloride 30 MG Oral Capsule nicardipine hydrochloride	3,061	60.4%	T3	0%	1,049
betaxolol hydrochloride 10 MG Oral Tablet betaxolol hydrochloride	3,059	60.4%	T2	0%	7,458
betaxolol hydrochloride 20 MG Oral Tablet betaxolol hydrochloride	3,059	60.4%	T2	0%	7,458
1.7 ML denosumab-bbdz 70 MG/ML Injection [Wyost] denosumab-bbdz	3,041	60%	T4	89.9%	-
28 ACTUAT teriparatide 0.02 MG/ACTUAT Pen Injector [Bonsity]	3,037	59.9%	T4	98.8%	-
Pediatric 1.5 ML leuprolide acetate 30 MG/ML Prefilled Syringe [Lupron] Pediatric	3,028	59.8%	T4	93.7%	-
24 HR diltiazem hydrochloride 180 MG Extended Release Oral Tablet diltiazem hydrochloride	3,028	59.8%	T2	0%	-
24 HR diltiazem hydrochloride 420 MG Extended Release Oral Tablet diltiazem hydrochloride	3,028	59.8%	T2	0%	-
Soft Gelatin methoxsalen 10 MG Oral Capsule Soft Gelatin methoxsalen	3,024	59.7%	T4	0%	-
sofosbuvir 400 MG / velpatasvir 100 MG Oral Tablet [Epclusa] sofosbuvir	3,020	59.6%	T4	99.3%	18
sofosbuvir 200 MG / velpatasvir 50 MG Oral Tablet [Epclusa] sofosbuvir	3,019	59.6%	T4	99.3%	18
sofosbuvir 200 MG / velpatasvir 50 MG Oral Pellet [Epclusa] sofosbuvir	3,019	59.6%	T4	99.3%	18
sofosbuvir 150 MG / velpatasvir 37.5 MG Oral Pellet [Epclusa] sofosbuvir	3,019	59.6%	T4	99.3%	18
0.4 ML cyclosporine 0.5 MG/ML Ophthalmic Suspension [Restasis] cyclosporine	3,017	59.5%	T3	0%	492,479
erythromycin ethylsuccinate 400 MG Oral Tablet erythromycin ethylsuccinate	3,002	59.2%	T3	0%	1,861
betamethasone 0.5 MG/ML / clotrimazole 10 MG/ML Topical Lotion betamethasone	2,999	59.2%	T3	0%	407,711
doxercalciferol 0.0005 MG Oral Capsule doxercalciferol	2,980	58.8%	T3	24.2%	317
doxercalciferol 0.001 MG Oral Capsule doxercalciferol	2,980	58.8%	T3	24.2%	317
doxercalciferol 0.0025 MG Oral Capsule doxercalciferol	2,980	58.8%	T3	24.2%	317
desoximetasone 2.5 MG/ML Topical Cream desoximetasone	2,979	58.8%	T3	0%	27,754
crisaborole 0.02 MG/MG Topical Ointment [Eucrisa] crisaborole	2,976	58.7%	T3	75.5%	5,637
amlodipine 5 MG / hydrochlorothiazide 12.5 MG / valsartan 160 MG Oral Tablet amlodipine	2,970	58.6%	T3	0%	11,575,402
amlodipine 5 MG / hydrochlorothiazide 25 MG / valsartan 160 MG Oral Tablet amlodipine	2,970	58.6%	T3	0%	11,575,402
amlodipine 10 MG / hydrochlorothiazide 12.5 MG / valsartan 160 MG Oral Tablet amlodipine	2,970	58.6%	T3	0%	11,575,402
amlodipine 10 MG / hydrochlorothiazide 25 MG / valsartan 160 MG Oral Tablet amlodipine	2,970	58.6%	T3	0%	11,575,402
clobetasol propionate 0.5 MG/ML Medicated Shampoo [Clodan] clobetasol propionate	2,967	58.6%	T3	0%	1,250,981
24 HR diltiazem hydrochloride 180 MG Extended Release Oral Tablet [Matzim] diltiazem hydrochloride	2,962	58.5%	T2	0%	-
24 HR diltiazem hydrochloride 240 MG Extended Release Oral Tablet [Matzim] diltiazem hydrochloride	2,962	58.5%	T2	0%	-
24 HR diltiazem hydrochloride 300 MG Extended Release Oral Tablet [Matzim] diltiazem hydrochloride	2,962	58.5%	T2	0%	-
24 HR diltiazem hydrochloride 360 MG Extended Release Oral Tablet [Matzim] diltiazem hydrochloride	2,962	58.5%	T2	0%	-
24 HR diltiazem hydrochloride 420 MG Extended Release Oral Tablet [Matzim] diltiazem hydrochloride	2,962	58.5%	T2	0%	-
24 HR trandolapril 2 MG / verapamil hydrochloride 240 MG Extended Release Oral Tablet trandolapril	2,961	58.4%	T2	0%	-
24 HR trandolapril 4 MG / verapamil hydrochloride 240 MG Extended Release Oral Tablet trandolapril	2,961	58.4%	T2	0%	-
120 ACTUAT formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.05 MG/ACTUAT Metered Dose Inhaler [Dulera]	2,956	58.3%	T3	10.8%	70,485
120 ACTUAT formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.2 MG/ACTUAT Metered Dose Inhaler [Dulera]	2,956	58.3%	T3	10.8%	70,485
120 ACTUAT formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.1 MG/ACTUAT Metered Dose Inhaler [Dulera]	2,956	58.3%	T3	10.8%	70,485
amlodipine 10 MG / hydrochlorothiazide 25 MG / valsartan 320 MG Oral Tablet amlodipine	2,955	58.3%	T3	0%	11,575,402
alanine 21.7 MG/ML / arginine 14.7 MG/ML / aspartate 4.34 MG/ML / glutamate 7.49 MG/ML / glycine 10.4 MG/ML / histidine 8.94 MG/ML / isoleucine 7.49 MG/ML / leucine 10.4 MG/ML / lysine 11.8 MG/ML / methionine 7.49 MG/ML / phenylalanine 10.4 MG/ML / proline 8.94 MG/ML / serine 5.92 MG/ML / threonine 7.49 MG/ML / tryptophan 2.5 MG/ML / tyrosine 0.39 MG/ML / valine 9.6 MG/ML Injectable Solution [Clinisol 15] alanine	2,954	58.3%	T3	97.4%	-
24 HR trandolapril 2 MG / verapamil hydrochloride 180 MG Extended Release Oral Tablet trandolapril	2,952	58.3%	T2	0%	-
triamcinolone acetonide 0.001 MG/MG Oral Paste [Kourzeq] triamcinolone acetonide	2,949	58.2%	T2	0%	3,621,019
miconazole nitrate 200 MG Vaginal Insert miconazole nitrate	2,938	58%	T2	0%	2,096
indomethacin 50 MG Oral Capsule indomethacin	2,922	57.7%	T2	20.4%	123,532
indomethacin 25 MG Oral Capsule indomethacin	2,922	57.7%	T2	20.4%	123,532
apremilast 30 MG Oral Tablet [Otezla] apremilast	2,916	57.5%	T4	99.6%	26,816
{4 (apremilast 10 MG Oral Tablet [Otezla]) / 4 (apremilast 20 MG Oral Tablet [Otezla]) / 47 (apremilast 30 MG Oral Tablet [Otezla]) } Pack [Otezla 28-Day 10/20/30 Starter Pack] apremilast	2,916	57.5%	T4	99.6%	26,811
levalbuterol 0.21 MG/ML Inhalation Solution levalbuterol	2,916	57.5%	T3	99.3%	6,922
loteprednol etabonate 0.0038 MG/MG Ophthalmic Gel [Lotemax] loteprednol etabonate	2,915	57.5%	T3	0%	91,483
apremilast 20 MG Oral Tablet [Otezla] apremilast	2,910	57.4%	T4	99.6%	26,816
{4 (apremilast 10 MG Oral Tablet [Otezla]) / 51 (apremilast 20 MG Oral Tablet [Otezla]) } Pack [Otezla 28-Day 10/20 Starter Pack] apremilast	2,910	57.4%	T4	99.6%	26,811
12 HR amoxicillin 1000 MG / clavulanate 62.5 MG Extended Release Oral Tablet amoxicillin	2,906	57.4%	T3	0%	-
levalbuterol 0.417 MG/ML Inhalation Solution levalbuterol	2,902	57.3%	T3	97.8%	6,922
24 HR trandolapril 1 MG / verapamil hydrochloride 240 MG Extended Release Oral Tablet trandolapril	2,894	57.1%	T2	0%	-
tenofovir alafenamide 25 MG Oral Tablet [Vemlidy] tenofovir alafenamide	2,893	57.1%	T4	14%	13,612
cyproheptadine hydrochloride 4 MG Oral Tablet cyproheptadine hydrochloride	2,883	56.9%	T3	58.3%	66,484

← Previous Page 33 of 61 Next →

Source: CMS Quarterly Prescription Drug Plan Formulary PUF 2026. 6,046 drugs with RXCUI identifiers from NLM RxNorm. Coverage percentages based on 0 active Part D plans.

Compiled by Plainmedicare Editorial, Health Insurance Editorial Team